Severe Septicemic Melioidosis in a Patient With Lung Adenocarcinoma Following Cytotoxic Chemotherapy

Kuo-Hwa Chiang, Kuo-Chen Cheng, Hsi-Hsing Yang

Abstract


Melioidosis is an endemic disease in Southeast Asia and northern Australia, caused by Burkholderia pseudomallei. Severe melioidosis pneumonia is typically life-threatening condition. It is relatively uncommon in patients with lung cancer. We report a case of melioidosis pneumonia with blood culture proved Burkholderia pseudomallei in a patient with advanced stage lung adenocarcinoma following treatment with a gemcitabine containing regimen. To our knowledge, this is the first report on septicemic melioidosis pneumonia in lung adenocarcinoma patients following administration of cytotoxic chemotherapy.




J Med Cases. 2015;6(1):14-16
doi: http://dx.doi.org/10.14740/jmc2012w

Keywords


Burkholderia pseudomallei; Septicemic melioidosis; Pneumonia; Lung adenocarcinoma; Cytotoxic chemotherapy

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.